law://eu/dec/2007/516@2026-11-14THE COMMISSION OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the European Community,Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary fieldnote, and in particular Article 20 thereof,Whereas:
HAS ADOPTED THIS DECISION:
| Antimicrobial | Cut-off value (mg/L) R > | |
|---|---|---|
| Campylobacter Jejuni | Erythromycin | 4 |
| Ciprofloxacin | 1 | |
| Tetracycline | 2 | |
| Streptomycin | 2 | |
| Gentamicin | 1 | |
| Campylobacter Coli | Erythromycin | 16 |
| Ciprofloxacin | 1 | |
| Tetracycline | 2 | |
| Streptomycin | 4 | |
| Gentamicin | 2 |
| (EUR) | |
| Member State | Maximum total amount for co-financing of sampling and analyses |
|---|---|
| Belgium — BE | 58092 |
| Bulgaria — BG | 58092 |
| Czech Republic — CZ | 58092 |
| Denmark — DK | 58092 |
| Germany — DE | 58092 |
| Estonia — EE | 14688 |
| Ireland — IE | 58092 |
| Greece — EL | 58092 |
| Spain — ES | 58092 |
| France — FR | 58092 |
| Italy — IT | 58092 |
| Cyprus — CY | 58092 |
| Latvia — LV | 18360 |
| Lithuania — LT | 58092 |
| Luxembourg — LU | 1836 |
| Hungary — HU | 58092 |
| Malta — MT | 58092 |
| Netherlands — NL | 58092 |
| Austria — AT | 58092 |
| Poland — PL | 58092 |
| Portugal — PT | 58092 |
| Romania — RO | 58092 |
| Slovenia — SI | 58092 |
| Slovakia — SK | 58092 |
| Finland — FI | 58092 |
| Sweden — SE | 58092 |
| United Kingdom — UK | 58092 |
| Total | 1429092 |
| Costs incurred related to functions at/by | Number of tests | Total costs of testing incurred during reporting period(national currency) |
|---|---|---|
| Bacteriological detection of Campylobacter spp. | ||
| Bacteriological detection of Salmonella spp. | ||
| Confirmation of Campylobacter spp. | ||
| Speciation of Campylobacter isolates | ||
| Enumeration of Campylobacter isolates | ||
| Serotyping of Salmonella isolates | ||
| Antimicrobial resistance testing of Campylobacter isolates |
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.